Search

Elaine W Hurt

from West Palm Beach, FL
Age ~44
Get Report
Also known as:
Elaine Wacuka, Elaine E
Phone and address:
401 N Rosemary Ave, West Palm Beach, FL 33401
Related to:
Mary M Ngati, 54R L Cleveland, 85Mary M Hurt, 54Mary Muthoni, 66Bobby E Hurt, 77Tim ClevelMary M NgatiMichelle J Cleveland, 47Mary M Hurt, 67Cadet Mercidieu, 64Timothy P Cleveland, 54
Connected to:
Adam Hurt, 49Alison R Hurt, 39Allie M Hurt, 58Alonzo L Hurt, 75Amelia R Hurt, 33Andrew J Hurt, 41Anthony D Hurt, 62Aven A Hurt, 31Brandy Hurt, 36Bryan L Hurt, 79

Elaine Hurt Phones & Addresses

  • 401 N Rosemary Ave, West Palm Bch, FL 33401
  • West Palm Beach, FL
  • Silver Spring, MD
  • Fort Lauderdale, FL
  • Washington, DC

Business Records

Name / Title
Company / Classification
Phones & Addresses
Elaine Hurt
Incorporator
L & H ELECTRIC CO

Publications

Us Patents

Compositions And Methods For Treating Cancer

View page
US Patent:
20210380673, Dec 9, 2021
Filed:
Jun 14, 2021
Appl. No.:
17/346876
Inventors:
- Gaithersburg MD, US
Elaine Marie HURT - Gaithersburg MD, US
International Classification:
C07K 16/24
C12N 15/113
A61P 35/00
G01N 33/574
Abstract:
The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express CCL20 and/or CCR6.

Bcma Monoclonal Antibody-Drug Conjugate

View page
US Patent:
20210214460, Jul 15, 2021
Filed:
Mar 29, 2021
Appl. No.:
17/215479
Inventors:
- Gaithersburg MD, US
Reena VARKEY - Gaithersburg MD, US
Xiaodong XIAO - Frederick MD, US
Elaine M. HURT - Gaithersburg MD, US
David TICE - Gaithersburg MD, US
International Classification:
C07K 16/30
C07K 16/28
A61K 47/68
A61P 35/00
A61K 31/202
A61K 31/4741
A61K 31/551
A61K 31/7048
C12N 15/62
Abstract:
The disclosure is directed to an antibody-drug conjugate (ADC) comprising a monoclonal antibody, or an antigen-binding fragment thereof, directed against B-cell maturation antigen (BCMA) conjugated to a cytotoxin. The disclosure also provides compositions comprising the antibody-drug conjugate and methods of killing multiple myeloma cells (including multiple myeloma stems cells) that express BCMA by contacting multiple myeloma cells with the ADC.

Compositions And Methods For Treating Cancer

View page
US Patent:
20200102382, Apr 2, 2020
Filed:
Oct 14, 2019
Appl. No.:
16/601140
Inventors:
- Gaithersburg MD, US
Elaine Marie HURT - Gaithersburg MD, US
International Classification:
C07K 16/24
A61P 35/00
G01N 33/574
C12N 15/113
Abstract:
The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express CCL20 and/or CCR6.

Bcma Monoclonal Antibody-Drug Conjugate

View page
US Patent:
20190040152, Feb 7, 2019
Filed:
Jul 31, 2018
Appl. No.:
16/050944
Inventors:
- Gaithersburg MD, US
Reena VARKEY - Gaithersburg MD, US
Xiaodong XIAO - Frederick MD, US
Elaine M. HURT - Gaithersburg MD, US
David TICE - Gaithersburg MD, US
International Classification:
C07K 16/30
A61P 35/00
C12N 15/62
A61K 31/7048
A61K 31/4741
A61K 31/202
A61K 31/551
A61K 47/68
Abstract:
The disclosure is directed to an antibody-drug conjugate (ADC) comprising a monoclonal antibody, or an antigen-binding fragment thereof, directed against B-cell maturation antigen (BCMA) conjugated to a cytotoxin. The disclosure also provides compositions comprising the antibody-drug conjugate and methods of killing multiple myeloma cells (including multiple myeloma stems cells) that express BCMA by contacting multiple myeloma cells with the ADC.

Compositions And Methods For Treating Cancer

View page
US Patent:
20180237515, Aug 23, 2018
Filed:
Jul 13, 2016
Appl. No.:
15/743384
Inventors:
- Gaithersburg MD, US
Elaine Marie HURT - Gaithersburg MD, US
International Classification:
C07K 16/24
G01N 33/574
A61P 35/00
Abstract:
The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express CCL20 and/or CCR6.
Control profile
Elaine W Hurt from West Palm Beach, FL, age ~44 Get Report